TC BioPharm (Holdings) plc Gains 45%
Thu, Mar 17, 2022 at 05:30 PM
TC BioPharm (Holdings) plc (TCBP:NASDAQ) jumped higher at $1.45, representing a gain of 45%. On Tue, Mar 15, 2022, TCBP:NASDAQ touched a New 2-Week Intraday Low of $0.89. The stock got featured on our News Catalysts scanner on Thu, Mar 17, 2022 at 10:07 AM in the 'BIOTECH' category. From Wed, Mar 02, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Wed, Mar 09, 2022 at $1.43 with a volume of 16M+.
About TC BioPharm (Holdings) plc (TCBP:NASDAQ)
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as...
Top 10 Gainers:
- Kidpik Corp. (PIK:NASDAQ), 158.15%
- Marrone Bio Innovations, Inc. (MBII:NASDAQ), 49.7%
- TC BioPharm (Holdings) plc (TCBP:NASDAQ), 45%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 40.25%
- Mullen Automotive Inc. (MULN:NASDAQ), 39.43%
- Synthetic Biologics, Inc. (SYN:NYSEMKT), 37.56%
- Orphazyme A/S (ORPH:NASDAQ), 37.4%
- Innodata Inc. (INOD:NASDAQ), 34.33%
- Neonode Inc. (NEON:NASDAQ), 33.02%
- Cingulate Inc. (CING:NASDAQ), 31.62%